Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

NCT00984529 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00984529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00984529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
February 28, 2010
Enrollment
500 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure